Sign in to view content

Treatment Switch From Aflibercept to Ranibizumab Pre-filled Syringe in Canadian DME Patients in a Real-World Setting: The PRECISE Study

Michel R Giunta, MD

Video
Published 2021

Related

Brolucizumab for the Treatment of Visual Impairment Due to Diabetic Macular Edema: 52-Week Results From the KESTREL and KITE Studies
David M. Brown, MD
Annual Meeting Talks
2021
The Impact of the COVID-19 Pandemic on Aflibercept and Ranibizumab Anti-VEGF Injections
Kapil Mishra, MD
On Demand Cases, Courses, and Papers
2021
The LADDER Trial of the Port Delivery System with Ranibizumab: Initial Study Results
Carl C. Awh, MD, FASRS
Updates from the Field
2018

Category: Diabetic Retinopathy

See more